Serum CTX: A New Marker of Bone Resorption That Shows Treatment Effect More Often Than Other Markers Because of Low Coefficient of Variability and Large Changes with Bisphosphonate Therapy

A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine

Dennis A. Hanson, Mary Ann Weis, Anne‐Marie Bollen et al. · Journal of Bone and Mineral Research · 1992 · 669 citations

Medicine, Biochemistry, Molecular Biology +17

Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption

Simon P. Robins, Henning W. Woitge, R. Hesley et al. · Journal of Bone and Mineral Research · 1994 · 324 citations

Medicine, Pathology, Bone Metabolism +15

Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen

Christian Rosenquist, Christian Fledelius, Stephan Christgau et al. · Clinical Chemistry · 1998 · 319 citations · Full text

Pharmacy, Immunology, Bone Metabolism +13

Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum

Baltazar Gomez, Shiva Ardakani, J Ju et al. · Clinical Chemistry · 1995 · 315 citations

Medicine, Biochemistry, Bone Metabolism +11

Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological Variability

R.A. Hannon, Aubrey Blumsohn, K.E. Naylor et al. · Journal of Bone and Mineral Research · 1998 · 262 citations

Medicine, Biochemistry, Endocrinology +17